JPMorgan Resumes Eli Lilly (LLY) at Overweight
Tweet Send to a Friend
JPMorgan analyst Chris Schott resumes coverage on Eli Lilly (NYSE: LLY) with a Overweight rating and a price ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE